Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EHRs Could Help Address Antibiotic Overprescribing For Viral Respiratory Infections – Study

Executive Summary

A recent study examining antibiotic prescribing patterns suggests that using electronic health records as a means of conveying surveillance data could help reduce the inappropriate use of antibiotics to treat viral respiratory infections.

You may also be interested in...



More Robust Health Information Exchange Needed To Boost Health IT Utilization – Bipartisan Policy Center

Getting the most out of the movement towards the use of electronic health records will depend on how well data are exchanged. The Bipartisan Policy Center offers recommendations on building a better environment for exchanging information.

Antibiotic Use Increases Under Medicare Part D, Study Finds

Study published in AMA's Archives of Internal Medicine shows evidence of increased and sometimes inappropriate antibiotics use since the start of Medicare's prescription drug program.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS054662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel